Theodore DeWeese

Last updated

Theodore L. DeWeese is an American radiation oncologist and academic administrator who is the fifteenth dean of the Johns Hopkins University School of Medicine and the third chief executive officer of Johns Hopkins Medicine. [1]

Life

DeWeese was raised in a housing project in Denver. [2] He earned a M.D. from the University of Colorado Health Sciences Center in 1990. [3]

DeWeese is a past president of the American Association for Radiation Oncology. [3] Following Paul B. Rothman's retirement, in the summer of 2022, DeWeese became the interim dean of Johns Hopkins School of Medicine and CEO of Johns Hopkins Hospital. [4] He assumed the roles on a permanent basis in December 2023. [4] [5]

Related Research Articles

<span class="mw-page-title-main">Johns Hopkins Hospital</span> Hospital in Maryland, U.S.

The Johns Hopkins Hospital (JHH) is the teaching hospital and biomedical research facility of Johns Hopkins School of Medicine in Baltimore, Maryland. Founded in 1889, Johns Hopkins Hospital and its school of medicine are considered to be the founding institutions of modern American medicine and the birthplace of numerous famed medical traditions, including rounds, residents, and house staff. Several medical specialties were founded at the hospital, including neurosurgery by Harvey Williams Cushing and Walter Dandy, cardiac surgery by Alfred Blalock, and child psychiatry by Leo Kanner. Johns Hopkins Children's Center which serves infants, children, teens, and young adults aged 0–21, is attached to the hospital.

<span class="mw-page-title-main">Johns Hopkins School of Medicine</span> Medical school of Johns Hopkins University

The Johns Hopkins University School of Medicine (JHUSOM) is the medical school of Johns Hopkins University, a private research university in Baltimore, Maryland. Founded in 1893, the School of Medicine shares a campus with Johns Hopkins Hospital and Johns Hopkins Children's Center, established in 1889.

The University of Maryland School of Medicine, located in Baltimore City, Maryland, U.S., is the medical school of the University of Maryland, Baltimore and is affiliated with the University of Maryland Medical Center and Medical System. Established in 1807 as the College of Medicine of Maryland, it is the first public and the fifth oldest medical school in the United States. UMB SOM's campus includes Davidge Hall, which was built in 1812, and is the oldest building in continuous use for medical education in the Northern Hemisphere.

<span class="mw-page-title-main">David Geffen School of Medicine at UCLA</span> Medical school of UCLA

The University of California, Los Angeles School of Medicine also known as the David Geffen School of Medicine at UCLA (DGSOM)—is an accredited medical school located in Los Angeles, California, United States. The school was renamed in 2001 in honor of media mogul David Geffen who donated $200 million in unrestricted funds. Founded in 1951, it is the second medical school in the University of California system, after the UCSF School of Medicine.

<span class="mw-page-title-main">Carey Business School</span> Graduate business school of Johns Hopkins University

The Johns Hopkins Carey Business School is the graduate business school of Johns Hopkins University, a private research university in Baltimore, Maryland. It was established in 2007 and offers full-time and part-time programs leading to the Master of Business Administration (MBA) and Master of Science (MS) degrees.

Ronald Joel Daniels is a Canadian academic and the current president of the Johns Hopkins University, a position which he assumed on March 2, 2009. Daniels' tenure in this role has been extended twice, and is currently set to run through 2029. Daniels was previously the vice-president and provost at the University of Pennsylvania, and prior to that was dean of the University of Toronto Faculty of Law. Daniels received his B.A. (1982) and J.D. (1986) degrees from the University of Toronto, and his LL.M. (1988) degree from Yale Law School.

Jeffrey R. Balser is the president and CEO of Vanderbilt University Medical Center (VUMC) and dean of the Vanderbilt University School of Medicine (VUSM). Balser is a 1990 graduate of the Vanderbilt M.D./Ph.D. program in pharmacology and subsequently completed residency training in anesthesiology and fellowship training in critical care medicine at Johns Hopkins. He continued to work at Johns Hopkins as a cardiac anesthesiologist and ICU physician before returning to Vanderbilt University and joining VUMC in 1998. Balser was appointed dean of the VUSM in 2008 and, the following year, was appointed the vice chancellor for health affairs at Vanderbilt, in charge of the medical center. He became president and CEO of VUMC in 2016 when the medical center became a financially distinct non-profit organization.

Paul Rodney McHugh is an American psychiatrist, researcher, and educator. He is currently the University Distinguished Service Professor of Psychiatry at the Johns Hopkins University School of Medicine and the author, co-author, or editor of seven books in his field.

<span class="mw-page-title-main">John E. Niederhuber</span>

John E. Niederhuber, MD was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.

<span class="mw-page-title-main">University of Utah School of Medicine</span> Medical school of the University of Utah

The University of Utah School of Medicine is located on the upper campus of the University of Utah in Salt Lake City, Utah. It was founded in 1905 and is currently the only MD-granting medical school in the state of Utah.

Carlos Alberto Pérez was an American radiation oncologist. He is well known for his contributions to the clinical management of patients, especially those with gynecologic tumors and carcinoma of the prostate, the breast and head and neck.

Professor Minesh P. Mehta, MD, FASTRO, is an American radiation oncologist and physician-scientist of Indian origin, Ugandan birth, Zambian Schooling and American Training, who contributed to the field of oncology for more than two and half decades.

<span class="mw-page-title-main">David Gorski</span> Science-based medicine advocate

David Henry Gorski is an American surgical oncologist and professor of surgery at Wayne State University School of Medicine. He specializes in breast cancer surgery at the Karmanos Cancer Institute. Gorski is an outspoken skeptic and critic of alternative medicine and the anti-vaccination movement. A prolific blogger, he writes as Orac at Respectful Insolence, and as himself at Science-Based Medicine where he is the managing editor.

<span class="mw-page-title-main">Paul B. Rothman</span>

Dr. Paul B. Rothman is the former Frances Watt Baker, M.D., and Lenox D. Baker Jr., M.D., Dean of the Medical Faculty, vice president for medicine at Johns Hopkins University, and former chief executive officer of Johns Hopkins Medicine. As dean and CEO, Dr. Rothman oversaw both the School of Medicine and the Johns Hopkins Health System, which together encompass six hospitals, hundreds of faculty and community physicians and a self-funded health plan.

Edward C. Halperin, is the chancellor and CEO of New York Medical College (NYMC) where he is also a professor of radiation medicine, pediatrics and history. He also serves as the Miriam Popack Chair in Biomedical Ethics and director of the Hirth and Samowitz Center for Medical Humanities and Holocaust Studies at NYMC, director of bioethics in the School of Health Sciences and Practice at NYMC, as well as provost for biomedical affairs for the Touro College and University System, a position he has held since 2012.

<span class="mw-page-title-main">Jonathan S. Lewin</span> American neuroradiologist

Jonathan S. Lewin is an American neuroradiologist specializing in medical imaging research with an emphasis on the investigation, development, and translation of new magnetic resonance imaging (MRI) techniques. He is the former executive vice president for health affairs (EVPHA) and executive director of the Woodruff Health Sciences Center for Emory University, and former President, CEO, and chairman of the board of Emory Healthcare. He currently serves as professor of radiology, biomedical engineering, and neurosurgery in the Emory School of Medicine and as professor of health policy and management in the Rollins School of Public Health.

Janet Howell Clark was an American physiologist and biophysicist.

Julie Ann Freischlag is an American vascular surgeon and current CEO of Atrium Health Wake Forest Baptist. She was the first female surgeon-in-chief of The Johns Hopkins Hospital and the first female chief of vascular surgery at the University of California, Los Angeles. In 2017, Freischlag was appointed Interim Dean of Wake Forest School of Medicine and CEO of the Wake Forest Baptist Medical Center. During the COVID-19 pandemic in North America, Freischlag was named chief academic officer of Atrium Health, Inc., and appointed the President-Elect of the American College of Surgeons.

Everett E. Vokes is an American oncologist. He is the John E. Ultmann Professor, chair of the Department of Medicine, and physician-in-chief at the University of Chicago Medical Center. In this role, he pioneered the combination radiation and chemotherapy as first-line treatment for head and neck cancer.

<span class="mw-page-title-main">Chi Van Dang</span> Hematological oncologist

Chi Van Dang is a hematological oncologist and researcher, currently serving as the Scientific Director of Ludwig Institute for Cancer Research. He is known for his research on genetics, the MYC gene and the cellular energy metabolism of cancer.

References

  1. "Theodore DeWeese welcomed as next dean and CEO OF Johns Hopkins Medicine". Office of Communications. Johns Hopkins University. December 20, 2023. Retrieved December 26, 2023.
  2. Worthington, Aliza (2023-12-08). "JHU appoints new medical school dean, Johns Hopkins Medicine CEO". Baltimore Fishbowl. Retrieved 2023-12-25.
  3. 1 2 "Theodore Leslie DeWeese, M.D., Professor of Radiation Oncology and Molecular Radiation Sciences". Johns Hopkins Medicine. Retrieved 2023-12-25.
  4. 1 2 Roberts, Angela (2023-12-08). "Johns Hopkins University names new CEO of Hopkins Medicine and dean of School of Medicine". Baltimore Sun. Retrieved 2023-12-25.
  5. "Theodore DeWeese appointed next dean and CEO of Johns Hopkins Medicine". The Hub. 2023-12-08. Retrieved 2023-12-25.